Anti-Infectives Week
Susan Hasty, Publisher
Table of Contents . . . May 3rd, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Anti-Infectives Week | Other Publications
Anti-Infectives - Suprax launched in the U.S.
Antimicrobials - Novel antibacterial agents for skin infections reviewed
Drug Resistance - Optimizing antibacterial therapy for respiratory infections described
Microbiology - Amoebae-resisting bacteria isolated from amoebal coculture
Pneumococcal Vaccine - Pneumococcal vaccine not useful in HIV patients responding to HAART
Tuberculosis Diagnostics - Varible Etest TB drug resistance results cause concern
Antibiotics - AACR data indicate strong synergy of Hsp90 inhibitor, 17-AAG
Antifungal Agents - CLEAR II registry launched
Antimicrobial Drug Resistance - Plasmodium falciparum drug resistance in India determined
Bacterial Vaginosis - Microbes that produce hydrogen peroxide reduce obstetrical complications
Business & Finance - PhotoPoint company reports progress during 2003, including lower net loss
Cancer Therapy - Studies support Targretin's activity in NSCLC
Cancer Vaccine - P-glycoprotein-derived peptides inhibited multidrug resistance of tumors
Decontamination - Italian government places $1.1 million initial order for SR-1
Dermatology - SkinRenu Plus maker announces worldwide launch of its products
Drug Development - Plasmodium vivax vivapains characterized
Drug Development - Novel assay provides improved measure of plasmodial Plm II activity
Drug Development - Novel ribonuclease has antimicrobial and antiproliferative activities
Drug Development - Novel sesquiterpene lactones show promise as antimalarial agents
Drug Development - Pyrrole BM212 derivatives have improved antimycobacterial activity
Drug Development - QSAR analysis on anti-HIV HEPT analogues described
Drug Resistance - Pyrrolopyrimidine a novel and selective MRP1 inhibitor
Epidemiology - Multilocus sequence Staphylococcus epidermidis typing effective
HIV/AIDS Gene Therapy - Recombinant AAV-2 useful as anti-HIV RNAi vector
HIV/AIDS Immune Control - HAART-induced recovery of HIV-specific immunity described
HIV/AIDS Opportunistic Infection - Dapsone-induced hypersensitivity pneumonitis can mimic PCP
HIV/AIDS Opportunistic Infection - Essential eukaryotic core identified from P. carinii
HIV/AIDS Opportunistic Infection - Visceral leishmaniasis relapse common during ineffective HAART
HIV/AIDS Therapy - Antiretroviral therapy does not prevent contingent negative variation
HIV/AIDS Therapy - Cessation of CMV retinitis therapy has no long-term sequelae for HIV patients
HIV/AIDS Therapy - Dose escalation unnecessary in patients switching to nevirapine from efavirenz
HIV/AIDS Therapy - Early IL-2 treatment increases CD4 cell count in HIV patients
HIV/AIDS Therapy - In utero AZT exposure has little or no impact on neurodevelopment
HIV/AIDS Therapy - Indinavir superior to ritonavir and saquinavir in triple therapies
HIV/AIDS Therapy - Indinavir/ritonavir/efavirenz regimen should benefit treatment-naive patients
HIV/AIDS Therapy - Pre-HAART IL-7 levels linked to long-term CD4 cell count
HIV/AIDS Therapy - Surgery can benefit patients with antiretroviral-induced "buffalo hump"
Hospital Pathogens - Antimicrobial technology granted EPA registration
Hospitalization - More hospitals offering private rooms and reducing nosocomial infection
Microbiology - Nonculturable bacteria thrive in the human urinary tract
Nosocomial Infection - Handrub promotion extremely cost-effective
Oncogenesis - Oncogenesis from single base mutation in IRES of Epstein-Barr nuclear antigen 1
Parasitology - Preventive practices eliminate the risk for congenital toxoplasmosis
Patents - U.S. patent filed for anti-sepsis compound
Periodontitis - Patient enrollment begins for phase III study of PeriostatMR
Personnel - Detlef Albrecht, MD, named chief medical officer of biopharma company
Proteomics - Up-regulation of ubiquitin-specific protease enhances EBV proliferation in vitro
Retrovirology - Nedd 4 or ubiquitin ligase Nedd4 regulates human T-cell leukemia virus type 1
Tuberculosis Diagnostics - Broth microdilution with 7H9 broth suitable as TB drug resistance test
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
